Top

Cancer Cell International

Published in:

Open Access 01-12-2022 | Glioblastoma | Research

Correlation of the prognostic value of FNDC4 in glioblastoma with macrophage polarization

Authors: Hongwu Li, Xiaofei Yan, Shaowu Ou

Published in: Cancer Cell International | Issue 1/2022

Abstract

Background

Glioblastoma is among the most malignant tumors in the central nervous system and characterized by strong invasion and poor prognosis. Fibronectin type III domain-containing 4 (FNDC4) plays various important roles in the human body, including participating in cellular metabolism and inflammatory responses to cardiovascular diseases, influencing immune cells, and exerting anti-inflammatory effects; however, the role of FNDC4 in glioblastoma has not been reported.

Methods

In this study, bioinformatics databases, including TCGA, CGGA, GTEx, and TIMER, were used to analyze the differential expression of FNDC4 genes and cell survival, in addition to investigating its relationship with immune cell infiltration. Additionally, we overexpressed FNDC4 in glioblastoma cell lines U87 and U251 by lentiviral transfection and detected changes in proliferation, cell cycle progression, and apoptosis. Following collection of monocytes from the peripheral blood of healthy individuals and transformation into M0 macrophages, we performed flow cytometry to detect the polarizing effect of exogenous FNDC4, as well as the effect of FNDC4-overexpressing glioblastoma cells on macrophage polarization in a co-culture system.

Results

We identified that significantly higher FNDC4 expression in glioblastoma tissue relative to normal brain tissue was associated with worse prognosis. Moreover, we found that FNDC4 overexpression in U87 and U251 cells resulted in increased proliferation and affected the S phase of tumor cells, whereas cell apoptosis remained unchanged. Furthermore, exogenous FNDC4 inhibited the M1 polarization of M0 macrophages without affecting M2 polarization; this was also observed in glioblastoma cells overexpressing FNDC4.

Conclusions

FNDC4 expression is elevated in glioblastoma, closely associated with poor prognosis, and promoted the proliferation of glioblastoma cells, affected the S phase of tumor cells while inhibiting macrophage polarization.

Available only for authorised users

Marx S, Xiao Y, Baschin M, Splittstöhser M, Altmann R, Moritz E, Jedlitschky G, Bien-Möller S, Schroeder H, Rauch B. The role of platelets in cancer pathophysiology: focus on malignant glioma. Cancers. 2019. https://doi.org/10.3390/cancers11040569.PubMedPubMedCentralCrossRef

Egaña L, Auzmendi-Iriarte J, Andermatten J, Villanua J, Ruiz I, Elua-Pinin A, Aldaz P, Querejeta A, Sarasqueta C, Zubia F, et al. Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia hospital. Sci Rep. 2020;10(1):18445.PubMedPubMedCentralCrossRef

Rahman M, Gras Navarro A, Brekke J, Engelsen A, Bindesbøll C, Sarowar S, Bahador M, Bifulco E, Goplen D, Waha A, et al. Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival. Br J Cancer. 2019;121(7):545–55.PubMedPubMedCentralCrossRef

Yin J, Zeng A, Zhang Z, Shi Z, Yan W, You Y. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma. EBioMedicine. 2019;42:238–51.PubMedPubMedCentralCrossRef

Olioso D, Caccese M, Santangelo A, Lippi G, Zagonel V, Cabrini G, Lombardi G, Dechecchi M. Serum exosomal microRNA-21, 222 and 124–3p as noninvasive predictive biomarkers in newly diagnosed high-grade gliomas: a prospective study. Cancers. 2021. https://doi.org/10.3390/cancers13123006.PubMedPubMedCentralCrossRef

Li R, Song Y, Fouladian P, Arafat M, Chung R, Kohlhagen J, Garg S. Three-dimensional printing of curcumin-loaded biodegradable and flexible scaffold for intracranial therapy of glioblastoma multiforme. Pharmaceutics. 2021. https://doi.org/10.3390/pharmaceutics13040471.PubMedPubMedCentralCrossRef

Porcù E, Maule F, Boso D, Rampazzo E, Barbieri V, Zuccolotto G, Rosato A, Frasson C, Viola G, Della Puppa A, et al. BMP9 counteracts the tumorigenic and pro-angiogenic potential of glioblastoma. Cell Death Differ. 2018;25(10):1808–22.PubMedPubMedCentralCrossRef

Niechi I, Uribe-Ojeda A, Erices J, Torres Á, Uribe D, Rocha J, Silva P, Richter H, San Martín R, Quezada C. Adenosine depletion as a new strategy to decrease glioblastoma stem-like cells aggressiveness. Cells. 2019. https://doi.org/10.3390/cells8111353.PubMedPubMedCentralCrossRef

Bosma M, Gerling M, Pasto J, Georgiadi A, Graham E, Shilkova O, Iwata Y, Almer S, Söderman J, Toftgård R, et al. FNDC4 acts as an anti-inflammatory factor on macrophages and improves colitis in mice. Nat Commun. 2016;7:11314.PubMedPubMedCentralCrossRef

10.

Kent W, Sugnet C, Furey T, Roskin K, Pringle T, Zahler A, Haussler D. The human genome browser at UCSC. Genome Res. 2002;12(6):996–1006.PubMedPubMedCentralCrossRef

11.

Wuensch T, Wizenty J, Quint J, Spitz W, Bosma M, Becker O, Adler A, Veltzke-Schlieker W, Stockmann M, Weiss S, et al. Expression analysis of fibronectin type III domain-containing (FNDC) genes in inflammatory bowel disease and colorectal cancer. Gastroenterol Res Pract. 2019;2019:3784172.PubMedPubMedCentralCrossRef

12.

Zhong M, Zhang Y, Yuan F, Peng Y, Wu J, Yuan J, Zhu W, Zhang Y. High FNDC1 expression correlates with poor prognosis in gastric cancer. Exp Ther Med. 2018;16(5):3847–54.PubMedPubMedCentral

13.

Yunwen C, Shanshan G, Zhifei B, Saijun C, Hua Y. The silencing of FNDC1 inhibits the tumorigenesis of breast cancer cells via modulation of the PI3K/Akt signaling pathway. Mol Med Rep. 2021. https://doi.org/10.3892/mmr.2021.12118.PubMedPubMedCentralCrossRef

14.

Tan M, Schaffalitzky de Muckadell O, Jøergensen M. Gene expression network analysis of precursor lesions in familial pancreatic cancer. J Pancreat Cancer. 2020;6(1):73–84.PubMedPubMedCentralCrossRef

15.

Xu H, Hu Y, Qiu W. Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B. Biomed Pharmacother. 2017;87:405–11.PubMedCrossRef

16.

Qi Z, Wang L, Qu X. lncRNA LINC00355 acts as a novel biomarker and promotes glioma biological activities via the regulation of miR-1225/FNDC3B. Dis Markers. 2021;2021:1683129.PubMedPubMedCentralCrossRef

17.

Wang B, Zheng B, Lu Y, Huang D, Liu J, Song J, Zheng S. FNDC4 acts as an extracellular factor to promote the invasiveness of hepatocellular carcinoma partly via the PI3K/Akt signalling pathway. Cancer Med. 2021;10(20):7242–52.PubMedPubMedCentralCrossRef

18.

Manfrini N, Mancino M, Miluzio A, Oliveto S, Balestra M, Calamita P, Alfieri R, Rossi R, Sassoè-Pognetto M, Salio C, et al. FAM46C and FNDC3A are multiple myeloma tumor suppressors that act in concert to impair clearing of protein aggregates and autophagy. Can Res. 2020;80(21):4693–706.CrossRef

19.

Boström P, Wu J, Jedrychowski M, Korde A, Ye L, Lo J, Rasbach K, Boström E, Choi J, Long J, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463–8.PubMedPubMedCentralCrossRef

20.

Elizondo-Montemayor L, Gonzalez-Gil AM, Tamez-Rivera O, Toledo-Salinas C, Peschard-Franco M, Rodriguez-Gutierrez NA, Silva-Platas C, Garcia-Rivas G. Association between Irisin, hs-CRP, and metabolic status in children and adolescents with type 2 diabetes mellitus. Mediators Inflamm. 2019;2019:6737318.PubMedPubMedCentralCrossRef

21.

Xiong X, Geng Z, Zhou B, Zhang F, Han Y, Zhou Y, Wang J, Gao X, Chen Q, Li Y, et al. FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity. Metab Clinl Exp. 2018. https://doi.org/10.1016/j.metabol.2018.01.013.CrossRef

22.

Pinkowska A, Podhorska-Okołów M, Dzięgiel P, Nowińska K. The role of Irisin in cancer disease. Cells. 2021. https://doi.org/10.3390/cells10061479.PubMedPubMedCentralCrossRef

23.

Tsiani E, Tsakiridis N, Kouvelioti R, Jaglanian A, Klentrou P. Current evidence of the role of the myokine irisin in Cancer. Cancers (Basel). 2021. https://doi.org/10.3390/cancers13112628.CrossRef

24.

Frühbeck G, Fernández-Quintana B, Paniagua M, Hernández-Pardos A, Valentí V, Moncada R, Catalán V, Becerril S, Gómez-Ambrosi J, Portincasa P, et al. FNDC4, a novel adipokine that reduces lipogenesis and promotes fat browning in human visceral adipocytes. Metabolism Clin Exp. 2020. https://doi.org/10.1016/j.metabol.2020.154261.CrossRef

25.

Pauletto M, Giantin M, Tolosi R, Bassan I, Barbarossa A, Zaghini A, Dacasto M. Curcumin mitigates AFB1-induced hepatic toxicity by triggering cattle antioxidant and anti-inflammatory pathways: a whole transcriptomic in vitro study. Antioxidants (Basel). 2020. https://doi.org/10.3390/antiox9111059.CrossRef

26.

Zhang LX, Du J, Zhao YT, Wang J, Zhang S, Dubielecka PM, Wei L, Zhuang S, Qin G, Chin YE, et al. Transgenic overexpression of active HDAC4 in the heart attenuates cardiac function and exacerbates remodeling in infarcted myocardium. J Appl Physiol. 2018;125(6):1968–78.PubMedPubMedCentralCrossRef

27.

Tang Y, Zeng Z, Wang J, Li G, Huang C, Dong X, Feng Z. Combined signature of nine immune-related genes: a novel risk score for predicting prognosis in hepatocellular carcinoma. Am J Transl Res. 2020;12(4):1184–202.PubMedPubMedCentral

28.

Chen L, Yi X, Goswami S, Ahn Y, Roybal J, Yang Y, Diao L, Peng D, Peng D, Fradette J, et al. Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppression. Oncoimmunology. 2016;5(11): e1234570.PubMedPubMedCentralCrossRef

29.

Anjum A, Yazid M, Fauzi Daud M, Idris J, Ng A, Selvi Naicker A, Ismail O, Athi Kumar R, Lokanathan Y. Spinal cord injury: pathophysiology, multimolecular interactions, and underlying recovery mechanisms. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms21207533.PubMedPubMedCentralCrossRef

30.

Howe MD, Furr JW, Munshi Y, Roy-O’Reilly MA, Maniskas ME, Koellhoffer EC, d’Aigle J, Sansing LH, McCullough LD, Urayama A. Transforming growth factor-beta promotes basement membrane fibrosis, alters perivascular cerebrospinal fluid distribution, and worsens neurological recovery in the aged brain after stroke. Geroscience. 2019;41(5):543–59.PubMedPubMedCentralCrossRef

31.

Mantovani A, Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol. 2010;22(2):231–7.PubMedCrossRef

32.

Murray P, Allen J, Biswas S, Fisher E, Gilroy D, Goerdt S, Gordon S, Hamilton J, Ivashkiv L, Lawrence T, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14–20.PubMedPubMedCentralCrossRef

33.

Holden J, Attard T, Laughton K, Mansell A, O’Brien-Simpson N, Reynolds E. Porphyromonas gingivalis lipopolysaccharide weakly activates M1 and M2 polarized mouse macrophages but induces inflammatory cytokines. Infect Immun. 2014;82(10):4190–203.PubMedPubMedCentralCrossRef

34.

Rostam H, Reynolds P, Alexander M, Gadegaard N, Ghaemmaghami A. Image based Machine Learning for identification of macrophage subsets. Sci Rep. 2017;7(1):3521.PubMedPubMedCentralCrossRef

35.

Maciuszek M, Klak K, Rydz L, Verburg-van Kemenade B, Chadzinska M. Cortisol metabolism in carp macrophages: a role for macrophage-derived cortisol in M1/M2 polarization. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms21238954.PubMedPubMedCentralCrossRef

36.

Coscia M, Quaglino E, Iezzi M, Curcio C, Pantaleoni F, Riganti C, Holen I, Mönkkönen H, Boccadoro M, Forni G, et al. Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. J Cell Mol Med. 2010;14(12):2803–15.PubMedCrossRef

37.

Porta C, Riboldi E, Ippolito A, Sica A. Molecular and epigenetic basis of macrophage polarized activation. Semin Immunol. 2015;27(4):237–48.PubMedCrossRef

38.

Zheng X, Turkowski K, Mora J, Brüne B, Seeger W, Weigert A, Savai R. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy. Oncotarget. 2017;8(29):48436–52.PubMedPubMedCentralCrossRef

39.

Yang S, Liu T, Cheng Y, Bai Y, Liang G. Immune cell infiltration as a biomarker for the diagnosis and prognosis of digestive system cancer. Cancer Sci. 2019;110(12):3639–49.PubMedPubMedCentralCrossRef

40.

Nunez RE, Del Valle MM, Ortiz K, Almodovar L, Kucheryavykh L. Microglial cytokines induce invasiveness and proliferation of human glioblastoma through Pyk2 and FAK activation. Cancers (Basel). 2021. https://doi.org/10.3390/cancers13246160.PubMedCentralCrossRef

41.

Ye X, Xu S, Xin Y, Yu S, Ping Y, Chen L, Xiao H, Wang B, Yi L, Wang Q, et al. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway. J Immunol. 2012;189(1):444–53.PubMedCrossRef

42.

Henrik Heiland D, Ravi V, Behringer S, Frenking J, Wurm J, Joseph K, Garrelfs N, Strähle J, Heynckes S, Grauvogel J, et al. Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma. Nat Commun. 2019;10(1):2541.PubMedPubMedCentralCrossRef

43.

Hull MA, Cuthbert RJ, Ko CWS, Scott DJ, Cartwright EJ, Hawcroft G, Perry SL, Ingram N, Carr IM, Markham AF, et al. Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc (Min/+) mouse model of intestinal tumorigenesis. Sci Rep. 2017;7(1):6074.PubMedPubMedCentralCrossRef

44.

Zhang J, Liu Y, Liu X, Li S, Cheng C, Chen S, Le W. Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model. Transl Neurodegener. 2018;7:35.PubMedPubMedCentralCrossRef

45.

Sun Y, Zhou YQ, Liu YK, Zhang HQ, Hou GG, Meng QG, Hou Y. Potential anti-neuroinflammatory NF-small ka, CyrillicB inhibitors based on 3,4-dihydronaphthalen-1(2H)-one derivatives. J Enzyme Inhib Med Chem. 2020;35(1):1631–40.PubMedPubMedCentralCrossRef

46.

Zhan X, Guo S, Li Y, Ran H, Huang H, Mi L, Wu J, Wang X, Xiao D, Chen L, et al. Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex-mediated STAT1 downregulation. J Exp Med. 2020. https://doi.org/10.1084/jem.20191340.PubMedPubMedCentralCrossRef

47.

Wu S, Watabe K. The roles of microglia/macrophages in tumor progression of brain cancer and metastatic disease. Front Biosci (Landmark edition). 2017;22(10):1805–29.CrossRef

48.

Wu A, Wei J, Kong L, Wang Y, Priebe W, Qiao W, Sawaya R, Heimberger A. Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol. 2010;12(11):1113–25.PubMedPubMedCentralCrossRef

Title: Correlation of the prognostic value of FNDC4 in glioblastoma with macrophage polarization
Authors: Hongwu Li
Xiaofei Yan
Shaowu Ou
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Glioblastoma
Glioblastoma
Glioblastoma
Published in: Cancer Cell International / Issue 1/2022
Electronic ISSN: 1475-2867
DOI: https://doi.org/10.1186/s12935-022-02688-7

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma

High AKAP8L expression predicts poor prognosis in esophageal squamous cell carcinoma

STAT3-mediated upregulation of LINC00520 contributed to temozolomide chemoresistance in glioblastoma by interacting with RNA-binding protein LIN28B

The B7H4-PDL1 classifier stratifies immuno-phenotype in cervical cancer

DNA methylome in pancreatic cancer identified novel promoter hyper-methylation in NPY and FAIM2 genes associated with poor prognosis in Indian patient cohort

LINC00467: an oncogenic long noncoding RNA

Keynote webinar | Spotlight on antibody–drug conjugates in cancer